Request Sample Inquiry
Therapeutic Vaccines Market

Therapeutic Vaccines Market

Therapeutic Vaccines Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

250

Base Year:

2023

Date

Jan - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2384

Segments Covered
  • By Product By Product Addiction Vaccines, Autoimmune Disease Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines
  • By Technology By Technology Autologous Vaccines, Allogeneic Vaccines
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 31 Billion
Revenue 2032Revenue 2032: USD 140 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 18.2%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Therapeutic Vaccines Market - Segment Analysis
    1. Overview
    2. Global Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
    3. Global Therapeutic Vaccines Market - by Product
      1. By Addiction Vaccines
      2. By Autoimmune Disease Vaccines
      3. By Neurological Disease Vaccines
      4. By Infectious Disease Vaccines
    4. Global Therapeutic Vaccines Market - by Technology
      1. By Autologous Vaccines
      2. By Allogeneic Vaccines
    5. Global Therapeutic Vaccines Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Therapeutic Vaccines Market - Segment Analysis
    1. Overview
    2. North America Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
    3. North America Therapeutic Vaccines Market, by Product
      1. By Addiction Vaccines
      2. By Autoimmune Disease Vaccines
      3. By Neurological Disease Vaccines
      4. By Infectious Disease Vaccines
    4. North America Therapeutic Vaccines Market, by Technology
      1. By Autologous Vaccines
      2. By Allogeneic Vaccines
    5. North America Therapeutic Vaccines Market, by Country
      1. U.S.
        1. U.S. Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. U.S. Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      2. Canada
        1. Canada Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Canada Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      3. Mexico
        1. Mexico Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Mexico Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
  5. Europe Therapeutic Vaccines Market - Segment Analysis
    1. Overview
    2. Europe Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
    3. Europe Therapeutic Vaccines Market, by Product
      1. By Addiction Vaccines
      2. By Autoimmune Disease Vaccines
      3. By Neurological Disease Vaccines
      4. By Infectious Disease Vaccines
    4. Europe Therapeutic Vaccines Market, by Technology
      1. By Autologous Vaccines
      2. By Allogeneic Vaccines
    5. Europe Therapeutic Vaccines Market, by Country
      1. Germany
        1. Germany Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Germany Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      2. UK
        1. UK Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. UK Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      3. France
        1. France Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. France Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      4. Spain
        1. Spain Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Spain Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      5. Italy
        1. Italy Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Italy Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      6. BENELUX
        1. BENELUX Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. BENELUX Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      7. Rest of Europe
        1. Rest Of Europe Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Rest Of Europe Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
  6. Asia Pacific Therapeutic Vaccines Market - Segment Analysis
    1. Overview
    2. Asia Pacific Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Therapeutic Vaccines Market, by Product
      1. By Addiction Vaccines
      2. By Autoimmune Disease Vaccines
      3. By Neurological Disease Vaccines
      4. By Infectious Disease Vaccines
    4. Asia Pacific Therapeutic Vaccines Market, by Technology
      1. By Autologous Vaccines
      2. By Allogeneic Vaccines
    5. Asia Pacific Therapeutic Vaccines Market, by Country
      1. China
        1. China Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. China Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      2. Japan
        1. Japan Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Japan Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      3. India
        1. India Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. India Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      4. South Korea
        1. South Korea Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. South Korea Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      5. South East Asia
        1. South East Asia Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. South East Asia Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Rest of Asia Pacific Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
  7. Latin America Therapeutic Vaccines Market - Segment Analysis
    1. Overview
    2. Latin America Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
    3. Latin America Therapeutic Vaccines Market, by Product
      1. By Addiction Vaccines
      2. By Autoimmune Disease Vaccines
      3. By Neurological Disease Vaccines
      4. By Infectious Disease Vaccines
    4. Latin America Therapeutic Vaccines Market, by Technology
      1. By Autologous Vaccines
      2. By Allogeneic Vaccines
    5. Latin America Therapeutic Vaccines Market, by Country
      1. Brazil
        1. Brazil Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Brazil Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      2. Argentina
        1. Argentina Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Argentina Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      3. Rest of Latin America
        1. Rest of Latin America Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Rest of Latin America Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
  8. Middle East & Africa Therapeutic Vaccines Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Therapeutic Vaccines Market, by Product
      1. By Addiction Vaccines
      2. By Autoimmune Disease Vaccines
      3. By Neurological Disease Vaccines
      4. By Infectious Disease Vaccines
    4. Middle East & Africa Therapeutic Vaccines Market, by Technology
      1. By Autologous Vaccines
      2. By Allogeneic Vaccines
    5. Middle East & Africa Therapeutic Vaccines Market, by Country
      1. GCC Countries
        1. GCC Countries Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. GCC Countries Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      2. South Africa
        1. South Africa Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. South Africa Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Therapeutic Vaccines Market, By Product
          1. By Addiction Vaccines
          2. By Autoimmune Disease Vaccines
          3. By Neurological Disease Vaccines
          4. By Infectious Disease Vaccines
        2. Rest of Middle East & Africa Therapeutic Vaccines Market, By Technology
          1. By Autologous Vaccines
          2. By Allogeneic Vaccines
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Agenus Inc. (U.S.)
    2. Argos Therapeutics Inc. (U.S.)
    3. Bavarian Nordic A/S (Denmark)
    4. Cel-Sci Corp. (U.S.)
    5. CSL Ltd. (Australia)
    6. Emergent Biosolutions Inc. (U.S.)
    7. GSK PLC (UK)
    8. Merck & Co. Inc. (U.S.)
    9. Pfizer Inc. (U.S.)
    10. Sanofi S.A. (France)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 15-Feb-2024
Therapeutic Vaccines Market to Reach Valuation of USD 140 Billion by 2030 – Adoption of Personalized Medicine and Advancements in Vaccine Technology Drives the Market
FAQ
Frequently Asked Question

  • The global Therapeutic Vaccines valued at USD 31 Billion in 2023 and is expected to reach USD 140 Billion in 2032 growing at a CAGR of 18.2%.

  • The prominent players in the market are Agenus Inc. (U.S.), Argos Therapeutics Inc. (U.S.), Bavarian Nordic A/S (Denmark), Cel-Sci Corp. (U.S.), CSL Ltd. (Australia), Emergent Biosolutions Inc. (U.S.), GSK PLC (UK), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Sanofi S.A. (France).

  • The market is project to grow at a CAGR of 18.2% between 2024 and 2032.

  • The driving factors of the Therapeutic Vaccines include

  • North America was the leading regional segment of the Therapeutic Vaccines in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy